Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Kestra Medical Technologies (KMTS) Preferred Shares Issued (2024)

Kestra Medical Technologies (KMTS) reported Preferred Shares Issued of $103.4 million for Q3 2024, up 727.2% on a QoQ basis from $12.5 million in Q2 2024.

Kestra Medical Technologies (KMTS) has 1 years of Preferred Shares Issued data on file, last reported at $103.4 million in Q3 2024.

  • Quarterly Preferred Shares Issued changed N/A year-over-year to $103.4 million in Q3 2024, while the trailing twelve-month figure through Apr 2025 was $103.4 million (changed N/A YoY) and the FY2025 annual result came in at $103.4 million, up 37.87% from the prior year.
  • Preferred Shares Issued rose to $103.4 million in Q3 2024 per KMTS's latest filing, from $12.5 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $103.4 million in Q3 2024 and bottomed at $12.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Kestra Medical Technologies 1.13 Bn 840.05 Mn 12.91 Mn -

Historic Data

Download Data 🔒
DateValue
Jul 31, 2024 103.40 Mn
Jul 31, 2024 103.40 Mn
Apr 30, 2024 12.50 Mn
Apr 30, 2024 12.50 Mn